Advisor Group Holdings, Inc. Revance Therapeutics, Inc. Transaction History

Advisor Group Holdings, Inc.

$42.2 Billion
Q3 2024

A detailed history of Advisor Group Holdings, Inc. transactions in Revance Therapeutics, Inc. stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 4,055 shares of RVNC stock, worth $10,421. This represents 0.0% of its overall portfolio holdings.

Number of Shares

4,055

Previous 3,414 18.78%

Holding current value

$10,421

Previous $8,000 25.0%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$2.57 - $2.57 $1,647 - $1,647	641 Added 18.78%	4,055 $10,000
Q2 2024 Aug 13, 2024	BUY	$2.34 - $4.73 $1,588 - $3,211	679 Added 24.83%	3,414 $8,000
Q1 2024 May 10, 2024	SELL	$4.65 - $9.31 $4,222 - $8,453	-908 Reduced 24.92%	2,735 $13,000
Q4 2023 Feb 12, 2024	SELL	$5.81 - $11.2 $5,170 - $9,968	-890 Reduced 19.63%	3,643 $32,000
Q3 2023 Nov 13, 2023	BUY	$11.47 - $25.07 $4,610 - $10,078	402 Added 9.73%	4,533 $51,000
Q2 2023 Aug 10, 2023	BUY	$24.7 - $37.61 $10,695 - $16,285	433 Added 11.71%	4,131 $104,000
Q1 2023 May 12, 2023	BUY	$18.36 - $35.27 $1,799 - $3,456	98 Added 2.72%	3,698 $119,000
Q4 2022 Feb 10, 2023	BUY	$18.32 - $30.66 $5,056 - $8,462	276 Added 8.3%	3,600 $66,000
Q3 2022 Nov 14, 2022	BUY	$14.33 - $28.47 $6,964 - $13,836	486 Added 17.12%	3,324 $90,000
Q1 2022 May 04, 2022	BUY	$12.36 - $20.31 $8,108 - $13,323	656 Added 30.06%	2,838 $56,000
Q3 2021 Nov 05, 2021	SELL	$25.78 - $33.21 $876 - $1,129	-34 Reduced 1.53%	2,182 $60,000
Q2 2021 Aug 02, 2021	BUY	$26.8 - $31.84 $6,458 - $7,673	241 Added 12.2%	2,216 $65,000
Q1 2021 May 13, 2021	SELL	$24.03 - $29.97 $1,970 - $2,457	-82 Reduced 3.99%	1,975 $55,000
Q4 2020 Feb 10, 2021	SELL	$23.41 - $28.34 $7,140 - $8,643	-305 Reduced 12.91%	2,057 $58,000
Q3 2020 Nov 12, 2020	BUY	$23.23 - $34.3 $17,352 - $25,622	747 Added 46.25%	2,362 $59,000
Q2 2020 Aug 14, 2020	SELL	$12.6 - $26.55 $10,130 - $21,346	-804 Reduced 33.24%	1,615 $39,000
Q1 2020 May 18, 2020	BUY	$12.46 - $27.81 $30,140 - $67,272	2,419 New	2,419 $37,000

Others Institutions Holding RVNC

# of Institutions

234

Shares Held

82.8M

Call Options Held

680K

Put Options Held

896K

View Full List

About Revance Therapeutics, Inc.

Ticker RVNC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 82,305,696
Market Cap $212M
Description
Revance Therapeutics, Inc., a biotechnology company, engages in the development, manufacture, and commercialization of neuromodulators for various aesthetic and therapeutic indications in the United States and internationally. The company's lead drug candidate is DaxibotulinumtoxinA for injection, which has completed phase III clinical trials fo...

More about RVNC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.

Account

Advisor Group Holdings, Inc. Revance Therapeutics, Inc. Transaction History